Weekly Reports | 10:00 AM
This week's In Brief's focuses on Catapult's SaaS growth, Hazer's clean hydrogen milestones and ResMed's portfolio repositioning through acquisitions and divestments.
- Catapult targets profitability as sports analytics market expands
- Hazer advances hydrogen projects and global licensing strategy
- ResMed bets on neuromodulation to strengthen its sleep care portfolio
By Danielle Ecuyer
This week's quote comes from Jarden:
We anticipate the commodities cycle may be undergoing a transition, from the 'Early Stage' (dominated by exploration activity) to the 'Peak Stage', which is likely to benefit industrials with greater exposure to production activity (Dyno Nobel; Orica).
"Using 20 years of financial disclosure from ALS, we see the typical 'Trough to Peak' cycle for the commodities segment lasts ~30 months.
"With our assessment of the trough this cycle being in 1H24, a slowdown in activity (geochemistry sampling flow growth) is a significant downside risk for investors given what we assess to be crowded positioning and a historically stretched (>1 St. Dev PE rel) relative valuation level."
SaaS-sy Catapult yet to become cash flow positive
Moelis initiated coverage on sports technology company Catapult Sports ((CAT)) this week. Catapult, market cap circa $1.1bn, specialises in wearable devices that capture data and analyse athlete performance across the spectrum.
The business has transitioned from selling wearables to a SaaS subscription model, where hardware and related services are typically provided under three-year contracts.
That strategic shift created a temporary distortion in the financial metrics, with equipment sales now recognised over the life of the contract rather than upfront. Conversely, margins have improved as upfront hardware costs have been replaced by depreciation expenses.
Moelis estimates the sports technology market is growing at around a 15% CAGR, driven by the ongoing commercialisation of professional sport and increasing investment from media and sports betting.
Catapult's devices are used by thousands of teams across more than 40 sports and 100 countries, with management seeking to differentiate the platform through proprietary algorithms that combine inertial and spatial data.
The broker highlights the latest Vector 8 device can generate more than 700 performance metrics from speed, distance, acceleration, orientation and heart-rate data. Wearable data is also integrated with the company's Tactics & Coaching solutions, including MatchTracker.
In October 2025, Catapult acquired SBG Sports Software for EUR78m, adding technology that can be applied across sports such as football, ice hockey and basketball, where player positioning is defined by the opposition rather than field markings.
Since FY21, the platform has added an average of 388 teams annually. If maintained, Moelis estimates Catapult could reach around 8,000 professional teams by 2036, representing around 40% of the current addressable market.
The broker expects the company to become EPS and cash flow positive in FY28 as revenue growth drives operating leverage and management works towards a 30% earnings (EBITDA) margin.
The stock is Buy rated with a $4.25 target.
Fresh milestones for Hazer Group
Shaw and Partners turned to Hazer Group's ((HZR)) 4Q26 update, which showed what the analyst views as a robust funding position, with $13m on hand at the end of FY26.
The funding comprises of $10.7m in cash and cash equivalents, plus $2.3m of potential funding related to a Western Australian government grant that has yet to be earned.
Against the analyst's forecast of $9.5m, the update is viewed positively and reflective of higher-than-expected free cash flow of around $1m.
Hazer is a clean technology company developing what is referred to as the Hazer Process, converting natural gas and related feedstocks into hydrogen and graphite by using iron ore as the catalyst.
Hazer and its commercial partner, Kellogg Brown & Root, have completed a Process Design Package for a 30ktpa hydrogen facility. The analyst highlights the package provides a standardised engineering template for future projects and helps de-risking the development process.
In terms of actual projects, the FortisBC project in British Columbia, Canada, has progressed from pilot scale towards the development of a 2,500tpa commercial facility, with Kellogg Brown & Root assisting with project development.
Hazer is also continuing to work with M Resources as part of its bid for the Whyalla Steelworks. That partnership is progressing the integration of Hazer's hydrogen and graphite technologies into low-emissions steelmaking.
POSCO and Hazer have also extended their collaboration through to 2028 to explore incorporating Hazer's technology into POSCO's low-carbon steelmaking pathway. Shaw notes Hazer's graphite has produced positive results across multiple steelmaking applications.
In the UK, a revenue-generating engineering study with EnergyPathways has increased the planned hydrogen production capacity to align with the Hazer-KBR commercial design package, representing another milestone for the company.
Shaw believes these June quarter highlights represent ongoing milestones for Hazer as management seeks to monetise its technology.
The stock is Buy rated, High Risk, with a 70c target price.
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE